Hannes Snellman Advised Charles River Laboratories, Inc. in the Divestment of Certain European Discovery Services Assets to IQVIA Holdings Inc.

Hannes Snellman acted as Finnish Counsel to Charles River Laboratories, Inc. in the divestment of certain European Discovery Services assets to IQVIA Holdings Inc. for approximately USD 145 million, with potential additional consideration of up to USD 10 million. The transaction comprises five sites across the UK, Germany, Finland, and the Netherlands, covering in vitro drug discovery services, including medicinal chemistry and structural biology, as well as pharmacology services in oncology, neuroscience, immunology, and advanced cell biology.

Hannes Snellman’s core advisory team comprised Erik Stenman (M&A), Niko Ojala (M&A), Sanna Honkinen (Employment), Jenni Parviainen (Tax) and Kerttu Kaksonen (Tax).